Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7540282 | TEVA PHARM | Reservoir pressure system for medicament inhaler |
May, 2023
(a month ago) | |
US7540282 (Pediatric) | TEVA PHARM | Reservoir pressure system for medicament inhaler |
Nov, 2023
(4 months from now) | |
US9616024 | TEVA PHARM | Process for preparing a medicament |
Sep, 2024
(1 year, 2 months from now) | |
US9987229 | TEVA PHARM | Process for preparing a medicament |
Sep, 2024
(1 year, 2 months from now) | |
US9987229 (Pediatric) | TEVA PHARM | Process for preparing a medicament |
Mar, 2025
(1 year, 8 months from now) | |
US9616024 (Pediatric) | TEVA PHARM | Process for preparing a medicament |
Mar, 2025
(1 year, 8 months from now) | |
US10765820 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(1 year, 11 months from now) | |
US9463288 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(1 year, 11 months from now) | |
US10765820 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(2 years from now) | |
US9463288 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(2 years from now) | |
US8651103 | TEVA PHARM | Dry powder inhalation apparatus |
Mar, 2028
(4 years from now) | |
US8651103 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Sep, 2028
(5 years from now) | |
US10195375 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2031
(7 years from now) | |
US10124131 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
US9731087 | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(7 years from now) | |
US10022510 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
US9216260 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jun, 2031
(8 years from now) | |
US10195375 (Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2031
(8 years from now) | |
US9731087 (Pediatric) | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
Nov, 2031
(8 years from now) | |
US10022510 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Nov, 2031
(8 years from now) | |
US10124131 (Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Nov, 2031
(8 years from now) | |
US9216260 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Dec, 2031
(8 years from now) | |
US10561808 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(8 years from now) | |
US8978966 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jan, 2032
(8 years from now) | |
US8714149 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2032
(8 years from now) | |
US10561808 (Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jul, 2032
(9 years from now) | |
US8978966 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jul, 2032
(9 years from now) | |
US8714149 (Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2032
(9 years from now) | |
US9415008 | TEVA PHARM | Dry powder inhaler |
Oct, 2034
(11 years from now) | |
US9066957 | TEVA PHARM | Dry powder inhaler |
Oct, 2034
(11 years from now) | |
US9415008 (Pediatric) | TEVA PHARM | Dry powder inhaler |
Apr, 2035
(11 years from now) | |
US9066957 (Pediatric) | TEVA PHARM | Dry powder inhaler |
Apr, 2035
(11 years from now) | |
US9782550 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(12 years from now) | |
US9782551 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(12 years from now) | |
US10918816 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Dec, 2035
(12 years from now) | |
US9782550 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2036
(12 years from now) | |
US9782551 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2036
(12 years from now) | |
US10918816 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Jun, 2036
(13 years from now) | |
US10569034 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2036
(13 years from now) | |
US10569034 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2037
(13 years from now) | |
US11351317 | TEVA PHARM | Drug delivery device with electronics |
Feb, 2038
(14 years from now) | |
US11351317 (Pediatric) | TEVA PHARM | Drug delivery device with electronics |
Aug, 2038
(15 years from now) | |
US11357935 | TEVA PHARM | Drug delivery device with electronics |
Sep, 2038
(15 years from now) | |
US11000653 | TEVA PHARM | Inhaler |
Dec, 2038
(15 years from now) | |
US11000653 (Pediatric) | TEVA PHARM | Inhaler |
Jun, 2039
(16 years from now) | |
US11344685 | TEVA PHARM | Drug delivery device with electronics |
Sep, 2039
(16 years from now) | |
US11344685 (Pediatric) | TEVA PHARM | Drug delivery device with electronics |
Mar, 2040
(16 years from now) | |
US11439777 | TEVA PHARM | Drug delivery device with electronics |
May, 2040
(16 years from now) | |
US11464923 | TEVA PHARM | Inhaler system |
Jun, 2040
(17 years from now) | |
US11173259 | TEVA PHARM | Drug delivery device with electronics and power management |
Jul, 2040
(17 years from now) | |
US11173259 (Pediatric) | TEVA PHARM | Drug delivery device with electronics and power management |
Jan, 2041
(17 years from now) | |
US11266796 | TEVA PHARM | Inhalation device with integrated electronics |
Feb, 2041
(17 years from now) | |
US11266796 (Pediatric) | TEVA PHARM | Inhalation device with integrated electronics |
Aug, 2041
(18 years from now) |
Exclusivity | Exclusivity Expiration |
---|---|
M (M) | Jul 9, 2024 |
Pediatric Exclusivity (PED) | Jan 9, 2025 |
Drugs and Companies using FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE ingredient
Market Authorisation Date: 27 January, 2017
Treatment: Treatment of asthma
Dosage: POWDER;INHALATION
99
United States
47
European Union
37
Japan
30
Spain
28
China
28
Israel
26
Korea, Republic of
24
Australia
22
Hong Kong
22
EA
21
Canada
21
Denmark
16
Poland
14
South Africa
11
Hungary
11
Portugal
9
Taiwan
9
Cyprus
8
Peru
7
Slovenia
7
United Kingdom
7
Argentina
7
Mexico
6
Austria
5
Brazil
5
Germany
5
Uruguay
5
New Zealand
3
Chile
3
RS
3
Croatia
3
San Marino
1
Philippines
1
Ukraine
1
Turkey
1
Morocco
1
IB
1
Colombia
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7540282 | TEVA PHARM | Reservoir pressure system for medicament inhaler |
May, 2023
(a month ago) | |
US7540282 (Pediatric) | TEVA PHARM | Reservoir pressure system for medicament inhaler |
Nov, 2023
(4 months from now) | |
US9616024 | TEVA PHARM | Process for preparing a medicament |
Sep, 2024
(1 year, 2 months from now) | |
US9616024 (Pediatric) | TEVA PHARM | Process for preparing a medicament |
Mar, 2025
(1 year, 8 months from now) | |
US10765820 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(1 year, 11 months from now) | |
US9463288 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(1 year, 11 months from now) | |
US9463288 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(2 years from now) | |
US10765820 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(2 years from now) | |
US8651103 | TEVA PHARM | Dry powder inhalation apparatus |
Mar, 2028
(4 years from now) | |
US8651103 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Sep, 2028
(5 years from now) | |
US10195375 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2031
(7 years from now) | |
US10124131 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
US9731087 | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(7 years from now) | |
US10022510 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
US9216260 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jun, 2031
(8 years from now) | |
US10195375 (Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2031
(8 years from now) | |
US10124131 (Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Nov, 2031
(8 years from now) | |
US10022510 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Nov, 2031
(8 years from now) | |
US9731087 (Pediatric) | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
Nov, 2031
(8 years from now) | |
US9216260 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Dec, 2031
(8 years from now) | |
US10561808 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(8 years from now) | |
US8978966 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jan, 2032
(8 years from now) | |
US8714149 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2032
(8 years from now) | |
US10561808 (Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jul, 2032
(9 years from now) | |
US8978966 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jul, 2032
(9 years from now) | |
US8714149 (Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2032
(9 years from now) | |
US9782550 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(12 years from now) | |
US9782551 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(12 years from now) | |
US10918816 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Dec, 2035
(12 years from now) | |
US9782550 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2036
(12 years from now) | |
US9782551 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2036
(12 years from now) | |
US10918816 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Jun, 2036
(13 years from now) | |
US10569034 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2036
(13 years from now) | |
US10569034 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2037
(13 years from now) | |
US11351317 | TEVA PHARM | Drug delivery device with electronics |
Feb, 2038
(14 years from now) | |
US11351317 (Pediatric) | TEVA PHARM | Drug delivery device with electronics |
Aug, 2038
(15 years from now) | |
US11357935 | TEVA PHARM | Drug delivery device with electronics |
Sep, 2038
(15 years from now) | |
US11000653 | TEVA PHARM | Inhaler |
Dec, 2038
(15 years from now) | |
US11357935 (Pediatric) | TEVA PHARM | Drug delivery device with electronics |
Mar, 2039
(15 years from now) | |
US11000653 (Pediatric) | TEVA PHARM | Inhaler |
Jun, 2039
(16 years from now) | |
US11344685 | TEVA PHARM | Drug delivery device with electronics |
Sep, 2039
(16 years from now) | |
US11344685 (Pediatric) | TEVA PHARM | Drug delivery device with electronics |
Mar, 2040
(16 years from now) | |
US11439777 | TEVA PHARM | Drug delivery device with electronics |
May, 2040
(16 years from now) | |
US11464923 | TEVA PHARM | Inhaler system |
Jun, 2040
(17 years from now) | |
US11173259 | TEVA PHARM | Drug delivery device with electronics and power management |
Jul, 2040
(17 years from now) | |
US11439777 (Pediatric) | TEVA PHARM | Drug delivery device with electronics |
Nov, 2040
(17 years from now) | |
US11464923 (Pediatric) | TEVA PHARM | Inhaler system |
Dec, 2040
(17 years from now) | |
US11173259 (Pediatric) | TEVA PHARM | Drug delivery device with electronics and power management |
Jan, 2041
(17 years from now) | |
US11266796 | TEVA PHARM | Inhalation device with integrated electronics |
Feb, 2041
(17 years from now) | |
US11266796 (Pediatric) | TEVA PHARM | Inhalation device with integrated electronics |
Aug, 2041
(18 years from now) |
Exclusivity | Exclusivity Expiration |
---|---|
New Patient Population (NPP) | Jul 9, 2024 |
New Strength (NS) | Jul 9, 2024 |
Pediatric Exclusivity (PED) | Jan 9, 2025 |
Drugs and Companies using FLUTICASONE PROPIONATE ingredient
Market Authorisation Date: 27 January, 2017
Treatment: NA
Dosage: POWDER;INHALATION
90
United States
45
European Union
35
Japan
29
Spain
27
Israel
26
China
24
Korea, Republic of
21
Australia
20
Denmark
20
EA
19
Canada
19
Hong Kong
15
Poland
13
South Africa
10
Hungary
10
Portugal
9
Cyprus
7
Slovenia
7
United Kingdom
7
Taiwan
6
Austria
6
Peru
5
Germany
5
Argentina
5
Uruguay
5
Mexico
4
Brazil
4
New Zealand
3
RS
3
Croatia
3
San Marino
1
Chile
1
Ukraine
1
Turkey
1
IB
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic